Aptevo Therapeutics Inc (APVO) stock is down -78.40% over the past 12 months, and Wall Street analysts’ average rating is Strong Buy. InvestorsObserver’s proprietary ranking system gives APVO shares a score of 27 out of a possible 100.
This rank is mainly influenced by a short-term technical rating of 0. APVO’s rank also includes a long-term technical rating of 0. The base rating for APVO is 79. In addition to the average rating from Wall Street analysts, APVO stock has an average price target of $ 52.50. This means that analysts expect the stock to gain 433.54% over the next 12 months.